|
|||||
![]() |
|
– | Sales decreased 2% year-over-year during the first quarter of 2025, attributable to promotional calendar differences | ||
– | Generated cash flows from operations of $484,000 during the first quarter of 2025 | ||
– | Declared a quarterly cash dividend of $0.20 per share | ||
LOS ANGELES, April 30, 2025 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended March 31, 2025.
First Quarter 2025 Financial Highlights
1 | Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period. | |
Management Commentary
"The 2% year-over-year revenue decrease was attributable to the timing of our incentive and promotional calendar between the two periods. However, we managed to sequentially increase orders taken by 9% over the fourth quarter of 2024, demonstrating sustained strong interest for our products and the value we provide to our customers,” commented Chris Sharng, President of Natural Health Trends Corp.
Mr. Sharng continued, “While the ever-evolving trade war is difficult to gauge, with the support of our product partners, we are actively working to align manufacturing closer to our key markets, shorten supply chains, and simplify logistics to weather the uncertainty and improve our long-term efficiency. Above all, our commitment to our members remains steadfast, and we will continue to deliver exceptional service and high-quality products to improve both their personal and financial well-being now and into the future."
Balance Sheet and Cash Flow
First Quarter 2025 Financial Results Conference Call
Management will host a conference call to discuss the first quarter 2025 financial results today, Wednesday, April 30, 2025 at 11:30 a.m. Eastern Time. The conference call details are as follows:
Date: | Wednesday, April 30, 2025 |
Time: | 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time |
Dial-in: | 1-877-407-0789 (Domestic) 1-201-689-8562 (International) |
Conference ID: | 13752084 |
Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1710105&tp_key=bcf30b6d42 |
For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on April 30, 2025 through 11:59 p.m. Eastern Time on May 14, 2025 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13752084.
About Natural Health Trends Corp.
Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.
Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 21, 2025 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.
CONTACT:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (U.S.): 310-541-0888
[email protected]
NATURAL HEALTH TRENDS CORP. CONSOLIDATED BALANCE SHEETS (In thousands, except share data) | ||||||||
March 31, 2025 | December 31, 2024 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 21,688 | $ | 13,533 | ||||
Marketable securities | 20,210 | 30,407 | ||||||
Inventories | 2,815 | 3,272 | ||||||
Other current assets | 4,093 | 3,771 | ||||||
Total current assets | 48,806 | 50,983 | ||||||
Property and equipment, net | 176 | 190 | ||||||
Operating lease right-of-use assets | 2,353 | 2,498 | ||||||
Restricted cash | 34 | 34 | ||||||
Deferred tax asset | 385 | 382 | ||||||
Other assets | 1,425 | 1,272 | ||||||
Total assets | $ | 53,179 | $ | 55,359 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 968 | $ | 895 | ||||
Income taxes payable | 4,915 | 4,908 | ||||||
Accrued commissions | 1,826 | 2,021 | ||||||
Other accrued expenses | 1,180 | 1,425 | ||||||
Deferred revenue | 6,921 | 6,428 | ||||||
Amounts held in eWallets | 3,296 | 3,286 | ||||||
Operating lease liabilities | 1,115 | 1,127 | ||||||
Other current liabilities | 522 | 709 | ||||||
Total current liabilities | 20,743 | 20,799 | ||||||
Deferred tax liability | 173 | 174 | ||||||
Operating lease liabilities | 1,381 | 1,514 | ||||||
Total liabilities | 22,297 | 22,487 | ||||||
Stockholders’ equity: | ||||||||
Preferred stock | — | — | ||||||
Common stock | 13 | 13 | ||||||
Additional paid-in capital | 84,935 | 84,901 | ||||||
Accumulated deficit | (28,525 | ) | (26,344 | ) | ||||
Accumulated other comprehensive loss | (1,144 | ) | (1,301 | ) | ||||
Treasury stock, at cost | (24,397 | ) | (24,397 | ) | ||||
Total stockholders’ equity | 30,882 | 32,872 | ||||||
Total liabilities and stockholders’ equity | $ | 53,179 | $ | 55,359 | ||||
NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (In thousands, except per share data) | ||||||||
Three Months Ended March 31, | ||||||||
2025 | 2024 | |||||||
Net sales | $ | 10,737 | $ | 10,951 | ||||
Cost of sales | 2,832 | 2,912 | ||||||
Gross profit | 7,905 | 8,039 | ||||||
Operating expenses: | ||||||||
Commissions expense | 4,488 | 4,486 | ||||||
Selling, general and administrative expenses | 3,762 | 3,918 | ||||||
Total operating expenses | 8,250 | 8,404 | ||||||
Loss from operations | (345 | ) | (365 | ) | ||||
Other income, net | 465 | 563 | ||||||
Income before income taxes | 120 | 198 | ||||||
Income tax provision (benefit) | (2 | ) | 10 | |||||
Net income | $ | 122 | $ | 188 | ||||
Net income per common share: | ||||||||
Basic | $ | 0.01 | $ | 0.02 | ||||
Diluted | $ | 0.01 | $ | 0.02 | ||||
Weighted average common shares outstanding: | ||||||||
Basic | 11,486 | 11,456 | ||||||
Diluted | 11,491 | 11,474 | ||||||
NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In thousands) | ||||||||
Three Months Ended March 31, | ||||||||
2025 | 2024 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net income | $ | 122 | $ | 188 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 30 | 35 | ||||||
Net accretion of marketable securities | (113 | ) | — | |||||
Share-based compensation | 34 | 37 | ||||||
Noncash lease expense | 275 | 272 | ||||||
Deferred income taxes | (2 | ) | (32 | ) | ||||
Changes in assets and liabilities: | ||||||||
Inventories | 465 | (640 | ) | |||||
Other current assets | 182 | 189 | ||||||
Other assets | (154 | ) | (101 | ) | ||||
Accounts payable | 73 | (239 | ) | |||||
Income taxes payable | 7 | 42 | ||||||
Accrued commissions | (214 | ) | 212 | |||||
Other accrued expenses | (259 | ) | 191 | |||||
Deferred revenue | 501 | 1,029 | ||||||
Amounts held in eWallets | 12 | (208 | ) | |||||
Operating lease liabilities | (281 | ) | (284 | ) | ||||
Other current liabilities | (194 | ) | (142 | ) | ||||
Net cash provided by operating activities | 484 | 549 | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Purchases of property and equipment | (16 | ) | (11 | ) | ||||
Purchases of marketable securities | (17,378 | ) | (28,514 | ) | ||||
Proceeds from maturities of marketable securities | 27,365 | — | ||||||
Net cash provided by (used in) investing activities | 9,971 | (28,525 | ) | |||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Dividends paid | (2,303 | ) | (2,303 | ) | ||||
Net cash used in financing activities | (2,303 | ) | (2,303 | ) | ||||
Effect of exchange rates on cash, cash equivalents and restricted cash | 3 | (76 | ) | |||||
Net increase (decrease) in cash, cash equivalents and restricted cash | 8,155 | (30,355 | ) | |||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period | 13,567 | 56,217 | ||||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period | $ | 21,722 | $ | 25,862 | ||||
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: | ||||||||
Right-of-use assets obtained in exchange for operating lease liabilities | $ | 79 | $ | 251 | ||||
20 hours | |
20 hours | |
Apr-30 | |
Apr-30 | |
Apr-30 | |
Apr-23 | |
Mar-20 | |
Mar-19 | |
Feb-06 | |
Feb-05 | |
Feb-05 | |
Jan-29 | |
Oct-31 | |
Oct-31 | |
Oct-30 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite